Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

GSK will not negotiate HER-2 Protein AutoVac vaccine deal

May 3, 2005

Updated survival data reported from phase I study of IL13-PE38QQR

May 3, 2005

Data from the HERA study support the use of Herceptin in early breast cancer

May 3, 2005

CR-064 neutralizes procancerous actions of ARP4

April 29, 2005

Dosing under way in phase I/II trial of ImmunoVEX-Trimelan

April 29, 2005

Phase I study assesses MT-201 with Taxotere for breast cancer treatment

April 29, 2005

Phase III trial studies panitumumab for first-line treatment of colorectal cancer

April 29, 2005

Herceptin improves disease-free survival in early breast cancer

April 28, 2005

CHIR-12.12 active against human multiple myeloma in preclinical studies

April 28, 2005

Promising results reported for SGN-40 in recurrent multiple myeloma

April 27, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...